B cell receptor signaling related to resistance to Helicobacter pylori eradication therapy in gastric diffuse large B cell lymphoma

Hematol Oncol. 2021 Feb;39(1):145-147. doi: 10.1002/hon.2816. Epub 2020 Oct 14.

Affiliations

¹ Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
² Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
³ Department of Anatomic Pathology, Graduate School of Medical Science, Kyushu University, Fukuoka, Japan.
⁴ Department of Internal Medicine, Division of Gastroenterology, Iwate Medical University, Morioka, Japan.

PMID: 33034903
DOI: 10.1002/hon.2816

No abstract available

Keywords: CARD11; Helicobacter pylori; MALT; gastric DLBCL.

Publication types

Letter

MeSH terms

Adult
Aged
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
Cyclophosphamide / administration & dosage
Doxorubicin / administration & dosage
Drug Resistance, Bacterial*
Female
Helicobacter Infections* / drug therapy
Helicobacter Infections* / metabolism
Helicobacter Infections* / pathology
Helicobacter pylori / metabolism*
Humans
Lymphoma, Large B-Cell, Diffuse* / drug therapy
Lymphoma, Large B-Cell, Diffuse* / metabolism
Lymphoma, Large B-Cell, Diffuse* / pathology
Male
Middle Aged
Prednisone / administration & dosage
Receptors, Antigen, B-Cell / metabolism*
Retrospective Studies
Rituximab / administration & dosage
Signal Transduction*
Stomach Neoplasms* / drug therapy
Stomach Neoplasms* / metabolism
Stomach Neoplasms* / pathology
Vincristine / administration & dosage

Substances

R-CHOP protocol
Receptors, Antigen, B-Cell
Rituximab
Vincristine
Doxorubicin
Cyclophosphamide
Prednisone